CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference | 06/18 08:00 | globenewswire.com |
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer | 06/17 16:15 | globenewswire.com |
Buy Alert: 3 Penny Stocks That Will Explode in 2024 | 06/05 06:00 | investorplace.com |
No Memes, Ma'am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock. | 05/29 06:25 | investorplace.com |
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference | 05/22 16:05 | globenewswire.com |
CytomX Therapeutics Announces New Employment Inducement Grants | 05/16 16:15 | globenewswire.com |
Why Is CytomX (CTMX) Stock Down 43% Today? | 05/09 11:56 | investorplace.com |
CytomX stock down 30% despite encouraging cancer study results | 05/09 09:10 | invezz.com |
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager) | 05/08 16:10 | globenewswire.com |
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | 05/08 16:10 | globenewswire.com |